BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2020 7:11:20 AM | Browse: 824 | Download: 1677
 |
Received |
|
2020-07-05 06:24 |
|
Peer-Review Started |
|
2020-07-05 06:24 |
|
First Decision by Editorial Office Director |
|
2020-07-30 18:01 |
|
Return for Revision |
|
2020-07-30 18:01 |
|
Revised |
|
2020-08-02 19:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-09-03 10:25 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-09-03 16:16 |
|
Articles in Press |
|
2020-09-03 16:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-07 00:28 |
|
Publish the Manuscript Online |
|
2020-09-11 07:11 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Stavroula Veneti and Konstantinos Tziomalos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomalos@yahoo.com |
| Key Words |
Diabetic nephropathy; Type 2 diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Liraglutide; Dulaglutide; Semaglutide |
| Core Tip |
Glucagon-like peptide-1 receptor agonists prevent the development of persistent macroalbuminuria in patients with type 2 diabetes mellitus. However, it is unclear whether they delay the decline in glomerular filtration rate in this population. Long-term trials are needed to clarify the role of these agents in the management of diabetic nephropathy. |
| Publish Date |
2020-09-11 07:11 |
| Citation |
Veneti S, Tziomalos K. Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy? World J Diabetes 2020; 11(9): 370-373
|
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i9/370.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i9.370 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
